mission-bio

Mission Bio raises Series B for single-cell sequencing

Mission Bio raises Series B for single-cell sequencing

The funding will enable the startup to expand its technology's role in discovering therapies for blood cancers and developing gene-editing technologies.

Mission Bio raises $10M for single-cell tumor analysis

Mission Bio raises $10M for single-cell tumor analysis

Mission Bio’s machine reads each cell’s DNA—the full blueprint.